UPMC Hillman Cancer Center

About

Welcome from Edward Chu, MD
Interim Director, UPMC Hillman Cancer Center

Edward Chu, MD UPMC Hillman Cancer Center is internationally recognized for their leadership in the prevention, detection, diagnosis, and treatment of cancer. As the preeminent institution in western Pennsylvania for the delivery of cancer care, the conduct of basic and translational research, and the education of the next generation of cancer researchers and physicians, UPMC Hillman Cancer Center is exceptionally well positioned to contribute to the global effort to reduce the burden of cancer.

UPMC Hillman Cancer Center’s integrated cancer care delivery network treats more than 74,000 patients each year for hematologic and oncologic disorders. As western Pennsylvania’s only National Cancer Institute (NCI)-designated Comprehensive Cancer Center, UPMC Hillman Cancer Center is quickly translating the latest research advances to clinical application for patients throughout the tristate region as well as those coming from other regions of the United States and beyond. UPMC Hillman Cancer Center is ranked 12th in NCI funding, including multiple competitive Specialized Program of Research Excellence (SPORE) grants focusing on head and neck, lung, and skin cancers, as well as a shared SPORE in ovarian cancer in collaboration with Roswell Park Cancer Institute.

The UPMC Hillman Cancer Center network represents more than 1,700 experts in surgical oncology, medical oncology, radiation oncology, otolaryngology, neuro-oncology, palliative care, behavioral medicine, and gynecologic oncology; scientists; administrative staff; and other health care professionals working together to reduce the burden of cancer. Through our hub-and-satellite network of more than 50 treatment centers in western Pennsylvania and Ohio, and a center in Ireland, Italy, and Singapore, cutting-edge treatments, sophisticated technologies, and as of January 2017, 495 clinical trials are available closer to home. The UPMC Hillman Cancer Center facility in Shadyside serves as the primary location for all UPMC cancer-related services, housing the key components of a full-service cancer center, including treatment facilities, disease-specific Cancer Specialty Care Centers, an education center, and a center for the prevention and early detection of cancer. The Shadyside center also accommodates a large portion of UPMC Hillman Cancer Center's laboratory research activities, allowing clinicians and scientists to work closely together to create the synergy that brings the best science from the lab to the patient.

This website, intended primarily for scientists and clinical investigators, contains information on our research and treatment progress, clinical trials, fellowship programs, funding opportunities, links to departmental newsletters, job postings, and bulletins about upcoming seminars and professional educational opportunities.

Patients and families can find extensive information about different cancers, and about our clinical programs, services, treatment locations and support services by visiting www.upmccancercenter.com.

We have designed this site to be easy to navigate. However, if you have difficulty finding the information you need, please contact the Webmaster at upciwebmaster@upmc.edu .

Edward Chu, MD
Interim Director, UPMC Hillman Cancer Center